New York University Langone

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Epilepsy1 trial
• Multiple myeloma1 trial
• Parkinson disease1 trial
• Postural tachycardia syndrome (POTS)1 trial

Phase

• Phase 11 trial
• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Celgene1 trial
• Duke University1 trial
• InSightec1 trial
• NeuroPace1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

  NCT07232069· Phase 3· Duke University· Source

  Contact: Harmony Reynolds, MD

• Active, not recruiting

  Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

  NCT04728295· InSightec· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting

Closed trials

• Completed

  Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

  NCT06593600· Phase 2· Regeneron Pharmaceuticals· Source

• Completed

  RNS System NAUTILUS Study

  NCT05147571· NeuroPace· Source

• Terminated

  Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

  NCT04855136· Phase 1· Celgene· Source